Francque Sven

发表

A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study.

Francque Sven, B. Pierre, F. Abdelmalek Manal, 2020, Contemporary clinical trials.